Astec LifeSciences Limited (ASTEC:NSE) Annual Income Statement ()
ASTEC:NSE Quarterly Financials ()
Frequently Asked Questions About Astec LifeSciences Limited (ASTEC:NSE) Stock
Astec LifeSciences Limited's (ASTEC:NSE) last reported annual revenue was INR 6.28 Billion.
Astec LifeSciences Limited's (ASTEC:NSE) annual revenue growth rate based on the revenue reported in the past 5 years is : 11.70%
Astec LifeSciences Limited's(ASTEC:NSE) is profitable as of its last reported annual financials.
The net profit margin for Astec LifeSciences Limited's(ASTEC:NSE) from its laster reported year is 4.07%
The return on equity (ROE) for Astec LifeSciences Limited's(ASTEC:NSE) from its last reported annual financials is : -6.28%
The return on assets (ROA) for Astec LifeSciences Limited's(ASTEC:NSE) from its last reported annual financials is : -1.14%
The return on invested capital (ROIC) for Astec LifeSciences Limited's(ASTEC:NSE) from its last reported annual financials is : 4.75%
The Debt to Equity ratio for Astec LifeSciences Limited's(ASTEC:NSE) from its last reported annual financials is : 2.59%
The dividend yield for Astec LifeSciences Limited's(ASTEC:NSE) from its laster reported year is 0.12%
Astec LifeSciences Limited's(ASTEC:NSE) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ASTEC:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
